Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bausch & Lomb Executives to Present At Investor Conferences Week of May 6, 2002.


Business Editors

ROCHESTER, N.Y.--(BUSINESS WIRE)--May 7, 2002

Bausch & Lomb (NYSE NYSE

See: New York Stock Exchange
:BOL BOL Bolivia (ISO Country code)
BOL Books Online
BOL Bole (SIL code, Nigeria)
BOL Bill Of Lading
BOL Beginning Of Line
BOL Best Of Luck
BOL Buzz Out Loud
BOL Bruin Online
BOL Beginning Of Life
) announced today that members of its management team are scheduled to present an overview of the Company's operations at two investor conferences this week.

Bausch & Lomb Chairman and Chief Executive Officer Ronald L. Zarrella is scheduled to make a presentation at the Deutsche Bank Deutsche Bank AG (IPA: /'dɔɪ.tʃə/[1]) (ISIN: DE0005140008, NYSE: DB) (English: German Bank  27th Annual Health Care Conference in Baltimore, Maryland "Baltimore" redirects here. For the surrounding county, see Baltimore County, Maryland. For other uses, see Baltimore (disambiguation).
Baltimore is an independent city located in the state of Maryland in the United States.
, on Wednesday, May 8, 2002.

Bausch & Lomb Chief Financial Officer Stephen C. McCluski is scheduled to make a presentation at the Robert W. Baird Robert Wilson Baird (born April 1, 1883) helped found the financial services firm that bears his name and led it for more than 40 years.

Baird’s father was a professor of Greek literature at Northwestern University in Evanston, Illinois, where Baird grew up.
 2002 Growth Stock Conference in Chicago, Illinois, on Friday, May 10, 2002.

The presentation will be posted on the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 page of the Company's web site, www.bausch.com, following the conferences.

Bausch & Lomb Incorporated is the preeminent global technology-based healthcare company for the eye, dedicated to helping consumers see, look and feel better through innovative technology. Its core businesses include soft and rigid gas permeable contact lenses, lens care products, ophthalmic surgical and pharmaceutical products. The company is advantaged with some of the most respected brands in the world starting with its name, Bausch & Lomb, and including SofLens, PureVision, Boston, ReNu, Storz and Technolas. Founded in 1853 in Rochester, N.Y., where it continues to have its headquarters, the company had revenues of approximately $1.7 billion in 2001, and employs approximately 12,000 people in more than 50 countries. Bausch & Lomb products are available in more than 100 countries around the world. Additional information about the company can be found on Bausch & Lomb's Worldwide Web site at http://www.bausch.com. Copyright Bausch & Lomb Incorporated
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 7, 2002
Words:268
Previous Article:Pioneer Introduces Pioneer High Income Trust -NYSE: PHH-; Portfolio Managed by Pioneer Investment Management, Inc. Merrill Lynch & Co. and UBS...
Next Article:ProxyMed Acquires KenCom Communications & Services, Inc.; Strengthens Presence and Multiple Offerings for Lab Industry.



Related Articles
Bausch & Lomb to Update Investors At Banc of America Securities Healthcare Conference On April 2, 2002.
Bausch & Lomb to Update Investors At Goldman Sachs Healthcare Conference On June 12, 2002.
Bausch & Lomb to Update Investors At Bear Stearns Healthcare Conference On September 18, 2002.
Bausch & Lomb to Update Investors At UBS Warburg Global Life Sciences Conference On October 8, 2002.
Bausch & Lomb to Update Investors At Salomon Smith Barney 2002 Health Care Conference October 30, 2002.
Bausch & Lomb Will Review Company Operations at Morgan Stanley's Inaugural Healthcare Conference on May 2, 2003.
Bausch & Lomb to Present at Robert W. Baird 2003 Growth Stock Conference May 14, 2003.
Bausch & Lomb to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare Conference June 10, 2003.
Bausch & Lomb to Present at UBS Global Life Sciences Conference September 22, 2003.
Bausch & Lomb to Present at Two Investor Conferences.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles